ClinicalTrials.Veeva

Menu

Preparing Heart and Mind™: A Patient Engagement Pathway for Parents and Their Caregiving Partners After a Major Fetal Anomaly Diagnosis

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Parent Mental Health

Treatments

Behavioral: PHM™ Pathway

Study type

Interventional

Funder types

Other

Identifiers

NCT05282368
SON-2019-27260

Details and patient eligibility

About

The purpose of this study is to test and evaluate the Preparing Heart and Mind™ (PHM™) patient engagement pathway as a nurse-guided intervention to lower psychological distress and enhance caregiving competencies among mothers/birthing persons and their caregiving partners after a major fetal anomaly diagnosis.

Enrollment

57 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A study participant can include a pregnant person past 20 weeks of pregnancy (this includes a vulnerable population)
  • Willing and able to comply with study procedures.
  • Participants must be ≥ 18 years old.
  • Participants must be able to read, write and speak English.
  • Participants must have access, and ability to use a smartphone, tablet, or computer in a private location.
  • The pregnant woman/person and her caregiving partner are planning for infant delivery and care.
  • The fetal diagnosis of the major anomaly affects the heart (i.e., CCHD). See definition of CCHD included earlier in the protocol. Other anomalies could be present and potentially impair other organs.
  • The infant's anomaly will likely require surgical and/or medical intervention within the first year of life.
  • The fetus/infant is expected to live with surgical and/or medical intervention (this includes a vulnerable population).
  • There may be genetic and/or chromosomal conditions in addition to the heart/structural anomalies

Exclusion criteria

  • Pregnancy termination
  • The fetal anomaly diagnosis is highly likely to result in fetal or infant demise shortly after birth.
  • Adults lacking the capacity to consent
  • Adults who do not have access to a smart phone, tablet, or device.
  • Caregiving partner cannot enroll if mother is not enrolled

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

57 participants in 2 patient groups

Intervention (PHM)
Experimental group
Description:
This pathway is intended to be a tool to enhance support for a mother/birthing person and her caregiving partner, facilitate communication with healthcare providers, and promote development of caregiving to optimize maternal-fetal, infant, and family health.
Treatment:
Behavioral: PHM™ Pathway
Usual Care Group (UC)
No Intervention group
Description:
The control group participants will receive care as usual.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems